FIBROUS DYSPLASIA OF BONE
Clinical trials for FIBROUS DYSPLASIA OF BONE explained in plain language.
Never miss a new study
Get alerted when new FIBROUS DYSPLASIA OF BONE trials appear
Sign up with your email to follow new studies for FIBROUS DYSPLASIA OF BONE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New injection aims to strengthen weakened bones in rare disorder
Disease control CompletedThis study tested whether a drug called burosumab could safely raise low phosphate levels in people with fibrous dysplasia, a condition that weakens bones. Twelve participants aged 1 and older received injections of the drug at home once or twice a month for 48 weeks. Researchers…
Matched conditions: FIBROUS DYSPLASIA OF BONE
Phase: PHASE2 • Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Disease control
Last updated Apr 04, 2026 08:21 UTC
-
New hope for stubborn bone pain when standard drugs fail
Disease control CompletedThis study tested whether the drug tocilizumab could help reduce bone pain and damage in people with fibrous dysplasia who still had pain after standard treatment. Researchers enrolled 19 patients who had already tried bisphosphonate drugs without enough relief. They compared toc…
Matched conditions: FIBROUS DYSPLASIA OF BONE
Phase: PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Apr 04, 2026 08:20 UTC
-
Scientists hunt for genetic fingerprint of rare bone disease
Knowledge-focused CompletedThis study aimed to understand why fibrous dysplasia, a rare bone condition, varies so much in severity between patients. Researchers looked for tiny genetic markers in the blood and bone tissue of 24 adults with the disease. The goal was to identify markers linked to more severe…
Matched conditions: FIBROUS DYSPLASIA OF BONE
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC